Some of the documents on this section of the CDRH Website are available only in PDF format and may not be accessible to those with certain disabilities. If you cannot access the documents you are interested in, please use the accessibility link for assistance. Below are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis.
A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available. Information about the PDF Reader is available.
PMA Original Approvals
3/16/06 |
LUMA Cervical Imaging System |
MediSpectra, Inc. Lexington, MA 02421 |
Approval for the LUMA Cervical Imaging System. The device is indicated for use as an adjunct to colposcopy for the identification of high-grade disease (CIN 2, 3+) in women referred to colposcopy with a Pap test result of atypical squamous cells (ASC), low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion or cancer (HSIL+). |
3/3/06 |
MonoPrep Pap Test (MPPT) |
MonoGen, Inc. Vernon Hills, IL 60061 |
Approval for the MonoPrep Pap Test (MPPT). The device is intended for use in collecting and preparing cervical-vaginal cytology specimens for Pap stain-based screening for cervical cancer, it's precursor lesions, and other cytological categories and conditions defined by The 2001 Bethesda System: terminology for reporting results of cervical cytology. The MonoPrep Pap Test produces slides that are intended to replace conventionally prepared Pap smear slides. |
3/24/06 |
DexCom STS Continuous Glucose Monitoring System |
DexCom, Inc. San Diego, CA 92121 |
Approval for the DexCom STS Continuous Glucose Monitoring System. The device is indicated for the following: 1) Indicated for detecting trends and tracking patterns in adults (18 and older) with diabetes and is intended for use by patients at home and in health care facilities. The device is for prescription use. 2) Indicated for use as an adjunctive device to complement, not replace, information obtained from standard home glucose monitoring devices. 3) Aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments, which may minimize these excursions. Interpretation of the STS System results should be based on the trends and patterns seen with several sequential sensor readings over time. |
PMA Supplemental Approvals
P820003/S078 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P820018/S074 3/14/06 180-Day |
Aurora/Quadra, Reflex, Simplex and Meta Pacemakers |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P830045/S093 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P830045/S094 3/14/06 180-Day |
Paragon, Phoenix, Multilog and Sensorithm Pacemakers |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P830045/S095 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P830055/S096 3/22/06 Special |
LCS Total Knee System |
DePuy Orthopaedics, Inc. Warsaw, IN 46581 |
Approval for an additional in-process inspection of the patella flange thickness for the Sigma P.F.C. RPF femoral components. |
P840001/S089 3/17/06 Real-Time |
Model 37701 RestorePRIME Implantable Neurostimulator (INS) |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for the Model 37701 RestorePRIME Implantable Neurostimulator (INS). |
P840001/S090 3/31/06 Real-Time |
Restore Implantable Neurostimulation System |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Model 37082 Dual Quadripolar Extension Kit (8-2-4). |
P850051/S062 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P860004/S076 3/27/06 180-Day |
SynchroMed II Programmable Drug Pump |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for a manufacturing site located at Medtronic Puerto Rico Operations Company, Juncos, Puerto Rico. |
P860004/S078 3/10/06 Real-Time |
SynchroMed Implantable Infusion System: Percutaneous Intraspinal Catheter Kit |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for inclusion of the B. Braun Medical Perifix Catheter Connector in the Model 8516 Percutaneous Intraspinal Catheter Kit. |
P860004/S079 3/22/06 180-Day |
SynchroMed Implantable Pump System |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for revised labeling for the manuals for the device. |
P860004/S081 3/22/06 Real-Time |
Model 8709 & 8731 Catheters |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for the following changes: 1) adding a sutureless pump connector to both Models 8709 and 8731 catheters compatible with the SynchroMed and IsoMed implantable infusion pumps; 2) adding numbers (in centimeters) to the markings on the 8709 catheter body like those on the 8731 catheter; 3) adding a shorter (9.3 cm) introducer needle to the Model 8731 kit; 4) adding connector pins and strain relief sleeves to Model 8731 catheter kit allowing the pump segment of the catheter to be trimmed; 5) create Model 8578 as a revision kit for 8709 or 8709SC (sutureless connector) containing the sutureless connector segment and strain relief sleeves; 6) adding Model 8598A for current 8598 kit (8731 spinal catheter segment revision kit) modified to contain the shorter (9.3 cm) introducer needle; and 7) Model 8596SC as the pump connector in the current 8596 kit (8731 pump catheter segment revision kit) was replaced with the sutureless pump connector. |
P860004/S082 3/30/06 Real-time |
SynchroMed II Programmable Drug Infusion System |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for the following modification: 1) shortening length of bulkhead inlet feature by 0.8 mm (0.03149 inches) from 3.0 mm to 2.2 mm; and 2) increasing radius of outer wall of bulkhead electronic chamber pocket by 0.3 mm (0.0118 inches) from 34.5 mm (1.358264 inches to 34.8 mm (1.370075 inches). |
P860057/S032 3/24/06 Real-Time |
Carpentier-Edwards PERIMOUNT Pericardial Biorosthesis, Models 2700TFX, 2800 TFX, 3000TFX and 6900PTFX |
Edwards Lifesciences LLC Irvine, CA 92614 |
Approval for protocols to be used to extend the shelf life beyond the current 2 years. |
P870025/S008 3/2/06 135-Day |
Fetal Acoustic Stimulator (FAST) - Corometrics Model 146 |
GE Medical Systems Information Technologies Tampa, FL 33614 |
Approval for vendor changes for the following components: die cast frame and printed circuit board (PCB) and a change in adhesive material. |
P880006/S036 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P880006/S037 3/14/06 180-Day |
Regency, Sensolog III, and Dialog II Pacemakers |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P880006/S038 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models | St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P880086/S113 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P880086/S114 3/14/06 180-Day |
Solus, Addvent, Solus II, Synchrony, Phoenix III, Trilogy, Affinity, Integrity, Entity, Identity, Verity and Victory Pacemakers |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P880086/S115 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P890003/S100 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P900022/S006 3/15/06 Real-Time |
CPR3 Programming Head for Chorus Models 6001, 6003, 6004, 6033, and 6034 |
ELA Medical, Inc. Plymouth, MN 55441 |
Approval for the hardware modification of the CPR3 programming head to be used with all the ELA's ICD and pacemaker systems. |
P900060/S032 3/30/06 180-Day |
CarboMedics Prosthetic Heart Valve, Carbo-Seal Ascending Aortic Prosthesis, and Carbo-Seal Valsalva Ascending Aortic prosthesis; Models 500, R500, S500, 700, S700, F500, F700, 100 and 200 |
CarboMedics Austin, TX 78752 |
Approval for a manufacturing site located at Sorin Group Canada, Inc., Mitroflow Division, Burnaby, British Columbia, Canada, to be used to assemble the sewing cuff. |
P900061/S062 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P900070/S031 3/14/06 180-Day |
Meta and Tempo Pacemakers |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P910023/S088 3/14/06 180-Day |
Epic II VR, Epic II DR, and Epic II+ DR Implantable Cardioverter Defibrillators (Models V-158, V-255, V-258) and Model 3307 v.6.0m Software |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P910023/S092 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P910023/S100 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P930022/S004 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P950022/S027 3/7/06 Real-Time |
Riata ST Models 7000, 7001, 7002, 7010, 7011, & 7012 |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for: 1) modifications to the Riata ST Models 7000, 7001 and 7002 active-fixation defibrillation leads to change the geometric profile of the inner coil and add white pigment to the medical adhesive used for shock coil backfill. 2) modifications to the Riata ST Models 7000, 7001, and 7002 leads to create an active-fixation integrated bipolar lead. These devices, as modified, will be marketed under the trade names Riata ST Models 7010, 7011, and 7012 and are indicated for use with compatible pulse generators. 3) modifications to the Riata ST Models 7000, 7001, and 7002 to create a passive fixation and a passive fixation integrated bipolar lead. These devices, as modified, will be marketed under the trade names Riata ST Models 7040, 7041 and 7042 (passive fixation) and Riata ST Models 7050, 7051, 7052 (passive fixation integrated bipolar) and are indicated for use with compatible pulse generators. |
P950022/S028 3/7/06 Real-Time |
Riata ST Passive Lead Models 7040, 7041, 7042, 7050, 7051 & 7052 |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for: 1) modifications to the Riata ST Models 7000, 7001 and 7002 active-fixation defibrillation leads to change the geometric profile of the inner coil and add white pigment to the medical adhesive used for shock coil backfill. 2) modifications to the Riata ST Models 7000, 7001, and 7002 leads to create an active-fixation integrated bipolar lead. These devices, as modified, will be marketed under the trade names Riata ST Models 7010, 7011, and 7012 and are indicated for use with compatible pulse generators. 3) modifications to the Riata ST Models 7000, 7001, and 7002 to create a passive fixation and a passive fixation integrated bipolar lead. These devices, as modified, will be marketed under the trade names Riata ST Models 7040, 7041 and 7042 (passive fixation) and Riata ST Models 7050, 7051, 7052 (passive fixation integrated bipolar) and are indicated for use with compatible pulse generators. |
P950029/S025 3/15/06 Real-Time |
CPR3 Programming Head for Chorus RM Model 7034; Opus RM Model 4534; Brio Models 112, 212, 220, 222; Talent 113, 213, 223; Opus G 4621, 4624; Talent II Models 133, 233; Symphony 2250, 2550; and ELA Rhapsody 2530, 2510, 2210 |
ELA Medical, Inc. Plymouth, MN 55441 |
Approval for the hardware modification of the CPR3 programming head to be used with all the ELA's ICD and pacemaker systems. |
P960009/S036 3/2/06 Real-Time |
Medtronic Activa Deep Brain Stimulation (DBS) Systems Models 3387S, 3389S DBS Leads |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for modifications to the Model 3387/3389 DBS Lead Kit intended for use with the Medtronic implantable systems for DBS. The modifications specified were: to remove the percutaneous extension, to add a lead cap, and to bundle the Medtronic Image-Guided Neurologics StimLoc Kit (burr hole cover assembly) with the DBS Lead Kit. |
P960009/S037 3/1/06 Special |
Medtronic Activa Deep Brain Stimulation (DBS), Model 7424 Itrell II Neurostimulator (DBS applications only), Model 7426 Soletra Neurostimulator, Model 7428 Kinetra Neurostimulator, Models 3387 & 3389 DBS Leads, Models 7582 & 7495 DBS Extensions |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for minor modifications to the labeling with respect to the MRI (magnetic resonance imaging) instructions; and for removing the “MRI and Activa Therapy”appendix from the labeling and replacing it with a stand-alone MRI guidelines document. |
P960043/S058 3/31/06 Special |
Prostar XL 8 & 10F PVS System |
Abbott Laboratories Redwood City, CA 94063 |
Approval for revised instructions for use. |
P960058/S053 3/22/06 Special |
HiResolution Bionic Ear System |
Advanced Bionics Corporation Sylmar, CA 91342 |
Approval for a modification to the Electrostatic Discharge (ESD) precaution in the HiResolution Bionic Ear System Package Insert. |
P970008/S029 3/23/06 180-Day |
Urologix Targis System |
Urologix, Inc. Minneapolis, MN 55447 |
Approval for the addition of a radio frequency identification (RFID) system to prevent reuse of the disposable device components. The device, as modified, will be marketed under the trade name Urologix Targis System and is indicated for the delivery of microwave energy to the prostate for the treatment of BPH in a single session. It is indicated for patients with prostatic lengths of 30 to 50 mm. |
P970008/S030 3/20/06 180-Day |
Urologix Targis System |
Urologix, Inc. Minneapolis, MN 55447 |
Approval for upgrades to the TargisSystem. These changes include improved appearance (which required replacing the Control Unit exterior panels and moving the user controls), improved electromagnetic compatibility (EMC), and other component and manufacturing modifications due to component obsolescence. |
P970012/S021 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P970013/S003 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P970013/S004 3/14/06 180-Day |
Microny Pacemakers |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P970013/S005 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P970030/S006 3/31/06 Special |
St Jude Medical Toronto SPV Valve, Model SPA-101 |
St. Jude Medical, Inc. St. Paul, MN 55117 |
Approval for changes to the Instruction for Use to add and strengthen cautions in the use of the device. |
P980016/S066 3/2/06 Real-Time |
Marquis DR/VR Models 7274, 7230B, 7230CX, 7230E; Maximo DR/VR Models 7278, 7232, 7232B, 7232E; Intrinsic Model 7288; Intrinsic 30J Model 7287; EnTrust 30J/35J ICD (D153ATG, D153DRG, D153VRC, D154ATG, D154 DRG, D154VRC) |
Medtronic, Inc. Shoreview, MN 55126 |
Approval for a change in hybrid components, the accelerometer (XE407) and tantalum capacitor (XT122) for the products previously listed. |
P980016/S067 3/2/06 Real-Time |
Medtronic EnTrust 30J/35J ICD Family Models D153ATG, D153DRG, D153VRC, D154ATG, D154DRG and D154VRC |
Medtronic, Inc. Shoreview, MN 55126 |
Approval for a minor design change to the ICR (Interconnect Ribbon) that connects the feedthroughs to the connector module blocks and multi beam contacts for the Medtronic EnTrust 30J/35J ICD Family (D153ATG, D153DRG, D153VRC, D154ATG, D154DRG, D154VRC). Specifically, the interconnect ribbon (ICR) that connects the feedthroughs to the connector module blocks and multi beam contacts is being modified to provide a lap-weld joint and the bonding of the same materials. |
P980016/S070 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P980035/S050 3/2/06 135-Day |
Implantable Pulse Generator, Model AT501 |
Medtronic, Inc. Shoreview, MN 55126 |
Approval for changes to the SRAM. |
P980035/S054 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P980049/S022 3/15/06 Real-Time |
CPR3 Programming Head for Defender II Model 9201; Defender IV Model 612; Alto Models 614 and 615; and Alto 2 Models 624 and 625 |
ELA Medical, Inc. Plymouth, MN 55441 |
Approval for the hardware modification of the CPR3 programming head to be used with all the ELA's ICD and pacemaker systems. |
P980050/S021 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P990001/S024 3/31/06 Real-Time |
Vitatron C60 DR Model C60A3, Vitatron C20 SR Model C20A3, Vitatron T60 DR Model T60A1, and Vitatron T20 SR Model T20A1 |
Vitatron Shoreview, MN 55123 |
Approval for software revisions. |
P990001/S025 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P990020/S020 3/17/06 180-Day |
AneuRx AAAdvantage stent Graft with Xcelerant Delivery System |
Medtronic Vascular Santa Rosa, CA 95403 |
Approval for additional iliac sizes (including 18mm and 20mm diameters; flared iliac and iliac cuffs in 16 mm x 20mm, 18mm x 22mm, and 18mm x 24mm); a longer aortic body of the bifurcated component by 1 cm; pre-shaped (contoured) stent rings; and Platinum-iridium radiopaque markets. The device, as modified, will be marketed under the trade name AneuRx AAAdvantage Stent Graft with Xcelerant Delivery system and is indicated for the endovascular treatment of infrarenal abdominal aortic or aorto-iliac aneurysms having: 1) Adequate iliac/femoral access; 2) Infrarenal, non-aneurysmal, neck length of greater than 1 cm at the proximal and distal ends of the aneurysm and an inner vessel diameter approximately 10-20% smaller than the labeled device diameter; 3) Morphology suitable for endovascular repair; 4) One of the following: aneurysm diameter > 5 cm; aneurysm diameter of 4-5 cm which has also increased in size by 0.5 cm in the last 6 months; or aneurysm which is twice the diameter of the normal infrarenal aorta. |
P990025/S011 3/28/06 Real-Time |
QwikStar Navigation/Ablation Catheter |
Biosense Webster, Inc. Palos Verdes Estates, CA 90274 |
Approval for a minor labeling revision for the 4 mm QwikStar Diagnostic/Ablation Catheter to include the NOGA XP Navigation System as an optional mapping system for the QwikStar catheter. The device, as modified, will be marketed under the same trade name and is indicated for catheter-based atrial and ventricular electrophysiological mapping and for use with compatible radio-frequency generators in adults and children four years of age or older in creating endocardial lesions during cardiac ablation procedures to treat arrhythmias. When used in the CARTO XP EP or NOGA XP Navigation Systems, the QwikStar Diagnostic/Ablation Catheter provides location information and approximate catheter tip curvature. |
P990027/S007 3/15/06 180-Day |
Bausch & Lomb TECHNOLAS 217z Zyoptix System for Personalized Vision Correction |
Bausch & Lomb, Inc. Rochester, NY 14609 |
Approval for: 1) an increase in the laser pulse repetition frequency from the current 50 Hz to 100 Hz; 2)replacement of the CeraTube Midi v.4.1 laser with the CeraTube Midi v.5.2 laser; 3) software revisions to accommodate the new laser and pulse rate; 4) labeling changes to document these modifications. |
P990034/S006 3/22/06 180-Day |
IsoMed Implantable Pump System |
Medtronic Neurological Minneapolis, MN 55432 |
Approval for revised labeling for the manuals for the device. |
P990050/S006 3/28/06 180-Day |
WavSTAT Optical Biopsy System |
SpectraScience, Inc. San Diego, CA 92121 |
Approval for a manufacturing site located at SpectraScience, Inc., San Diego, California. |
P000029/S016 3/1/06 Special |
Deflux Injectable Gel |
Q-Med Scandinavia, Inc. Princeton, NJ 08540 |
Approval for a quality control change resulting in additional assurance of the purity of the devices. |
P000043/S014 3/28/06 180-Day |
TherMatrx TMx-2000 BPH Thermotherapy System |
American Medical Systems Minnetonka, MN 55343 |
Approval for a transfer of packaging site of the rectal probes to American Medical Systems, Minnetonka, Minnesota and to generate package labels in house. |
P010014/S001 3/23/06 180-Day |
Oxford Meniscal Unicompartmental Knee System |
Biomet Manufacturing Corporation Warsaw, IN 46581 |
Approval of the post-approval study for the device. |
P010014/S004 3/31/06 135-Day |
Oxford Meniscal Unicompartmental Knee System |
Biomet Manufacturing Corporation Warsaw, IN 46581 |
Approval for a change in sterilization validation method from AAMI/IOS 11137 Method 1 to AAMI TIR 27. |
P010014/S008 3/15/06 Real-Time |
Oxford Meniscal Unicompartmental Knee System |
Biomet Manufacturing Corporation Warsaw, IN 46581 |
Approval for a product line extension to include a series of extra-small components (femoral, meniscal bearing, tibial tray) and a new series of anatomic (left and right specific) meniscal bearing components. |
P010015/S016 3/7/06 180-Day |
InSync III Biventricular Pacing System (Model 8041) |
Medtronic, Inc. Shoreview, MN 55126 |
Approval for modifications to the device labeling to describe the CARE-HF clinical study. Medtronic also requests a reformatting of the indications statement and the addition of a Clinical Outcomes section to the device labeling which includes claims based on the primary endpoint and two secondary endpoints in the CARE-HF study. The Medtronic InSync III Model 8042 is indicated for NYHA Functional Class III and IV patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section), and have a left ventricular ejection fraction = 35% and a prolonged QRS duration. Rate adaptive pacing is provided for those patients developing a bradycardia indication who might benefit from increased pacing rates concurrent with increases in activity. Dual chamber and atrial tracking modes are indicated for patients who may benefit from maintenance of AV synchrony. |
P010015/S021 3/31/06 Real-Time |
All Medtronic Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P010025/S008 3/29/06 180-Day |
Selenia Full field Digital Mammography System |
Hologic, Inc. Bedford, MA 01730 |
Approval for an optional product configuration of tungsten target with rhodium and silver filters in the x-ray system instead of molybdenum target with molybdenum and rhodium filters. |
P010031/S034 3/2/06 Real-Time |
InSync III Marquis Model 7279 ; InSync Sentry Models 7297, 7299 ; InSync II Marquis Model 7289 ; InSync II Protect Model 7295; InSync III Protect Model 7285; InSync Maximo Models 7303, 7304 ; InSync Marquis Models 7277 |
Medtronic, Inc. Shoreview, MN 55126 |
Approval for a change in hybrid components, the accelerometer (XE407) and tantalum capacitor (XT122) for the products previously listed. |
P010031/S037 3/31/06 Real-Time |
All Medtronic and Vitatron Pacemaker and ICD Models |
Medtronic, Inc. Minneapolis, MN 55432 |
Approval for the Medtronic Model 9986 Desktop/BOSS (software version 1.5.1) for the Medtronic Model 2090 CareLink Programmer for All Medtronic pacemaker and ICD models. It is to enhance internal |
P010033/S010 3/10/06 Special |
QuantiFERON-TB Gold |
Cellestis, Inc. Valencia, CA 91355 |
Approval for labeling change to the wording of the interpretation of the test to remove ambiguity and enhance safe use. |
P020018/S007 3/23/06 180-Day |
Zenith Flex AAA Endovascular Graft with the H&LB One-Shot |
Cook, Inc. Bloomington, IN 47402 |
Approval of the post-approval study submission for the Zenith Flex AAA Endovascular Graft with the H&LB One-Shot. |
P020035/S002 3/3/06 Real-Time |
X-Site Suture-Mediated Closure Device |
Datascope Corporation Mahwah, NJ 07430 |
Approval for various labeling changes and ergonomic changes to the device. The device, as modified, will be marketed under the trade name X-Site Suture-Mediated Closure Device and is indicated for “…the percutaneous delivery of suture for closing the common femoral artery access site of patients who have undergone diagnostic or interventional coronary catheterization procedures using sheaths less than or equal to 6 Fr. The X-Site Suture-Mediated Closure Device is intended to reduce the time to h0mostasis, time to ambulation (100 feet), and time to dischargeability in patients who have undergone diagnostic or interventional coronary catheterization procedures without complicating clinical conditions, including those receiving Glycoprotein IIb/IIIa inhibitors.” |
P030002/S006 3/3/06 180-Day |
crystaLens Model AT-45 Accommodating Intraocular Lens (IOL) |
Eyeonics, Inc. Aliso Viejo, CA 92656 |
Approval for updated physician labeling with 3-year clinical data. |
P030006/S008 3/31/06 180-Day |
Celsion Prolieve Thermodilatation System |
Celsion Corporation Columbia, MD 21046 |
Approval for software revisions and modification of the device operating system to Embedded Windows XP |
P030006/S009 3/15/06 180-Day |
Celsion Prolieve Thermodilatation System |
Celsion Corporation Columbia, MD 21046 |
Approval for multiple design modifications which affect the safety and effectiveness of the Prolieve device. |
P030035/S006 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P030035/S007 3/14/06 180-Day |
Frontier and Frontier II Biventricular Pacing Systems |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P030035/S008 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P030035/S010 3/2/06 Real-Time |
Frontier II Device Model 5586 |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for a new analog chip for use in the St. Jude Medical Frontier II device model 5586. |
P030039/S003 3/10/06 Special |
CoSeal Surgical Sealant |
Baxter Healthcare Corporation McGaw Park, IL 60085 |
Approval for labeling change to add a warning regarding use of the sealant to adhere objects to tissue. |
P030054/S019 3/14/06 180-Day |
Epic II HF Cardiac Resynchronization Therapy Defibrillator (Model V-355) and Model 3307 v.6.0m Software |
St. Jude Medical, CRMD Sunnyvale, CA 94086 |
Approval for modifications to the Epic II/Epic II+ and Epic II HF devices. The modifications include adding a vibratory patient notifier; modifying the electrogram morphology algorithm; modifying the capacitor maintenance feature; changing the materials of the can and header; and minor changes to packaging and software. The devices, as modified, will be marketed under the trade names Epic II/Epic II+ DR/VR/HF Implantable Cardioverter Defibrillator Systems (Models V-158, V-255, V-258, and V-355) and Model 3307 v. 6.0c Software. The Model 3307 v. 6.0m software interfaces with the above noted PMAs. The devices are indicated as follows: The Epic II and Epic II+ systems are intended to provide ventricular antitachycardia pacing and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias. For Epic II+ DR devices, AF suppression pacing is indicated for suppression of paroxysmal or persistent atrial fibrillation in patients with the above ICD indication and sinus node dysfunction. In patients indicated for an ICD, the Epic II HF system is also intended: 1)to provide a reduction of the symptoms of moderate to severe heart failure (NYHA Functional Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy (as defined in the clinical trials section) and have a left ventricular ejection fraction less than or equal to 35% and a prolonged QRS duration 2) to maintain synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic (permanent) atrial fibrillation and have NYHA Class II or III heart failure. |
P030054/S020 3/2/06 Real-Time |
Generator and Implantable Cardioverter Defibrillator (ICD) Families |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for Model 3330 Version 1.2 software supporting the Microny/Regency and Frontier devices on the Model 3650 Merlin Programmer. |
P030054/S022 3/7/06 Real-Time |
All Pacemaker, CRT-P, CRT-D and ICD Models |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Approval for the Model 3330 Version 2.0 Software for use on the Model 3650 Merlin Patient Care System. |
P040006/S002 3/29/06 180-Day |
CHARIT Artificial Disc |
DePuy Spine, Inc. Raynham, MA 02767 |
Approval for 1) new endplates coated with vacuum plasma-sprayed pure titanium and calcium phosphate; 2) three new intermediate endplate sizes utilizing this same coating; and 3) various surgical instruments to accommodate the proposed new endplates. |
P040012/S003 3/16/06 180-Day |
ACCULINK Carotid Stent System and RX ACCULINK Carotid Stent System |
Guidant Corporation Santa Clara, CA 95054 |
Approval of modifications to the protocol for the ARCHER Long Term Follow-up (LTFU) Trial. The revised protocol includes measures designed to assist in the recruitment and evaluation of patients, and complies with the conditions of approval outlined in the August 30, 2004 approval order for P040012. |
P040012/S008 3/27/06 Special |
ACCULINK and RX ACCULINK Carotid Stent System |
Guidant Corporation Santa Clara, CA 95054 |
Approval for the following changes: 1) Addition of a new catheter leak test to the manufacturing process; 2) Modifications to the radio force in-process testing parameters; 3) Increasing the stringency of the AQL for the distal junction test; 4) Addition of a microscopic visual inspection step to detect broken struts; and 5) Addition of an inspection step to verify that the adhesive was correctly applied and completely cured. |
P040012/S010 3/14/06 Real-Time |
ACCULINK and RX ACCULINK Carotid Stent System |
Guidant Corporation Santa Clara, CA 95054 |
Approval for removal of stent mass as a final product specification for the RX ACCULINK Carotid Stent System and modification of the specifications regarding allowable contaminant in the device packaging. |
P040013/S002 3/27/06 Real-Time |
GEM 21S (Growth-factor Enhance Matrix) |
Biomimetics Therapeutics, Inc. Franklin, TN 37067 |
Approval for expiry date of 24 months and is indicated to treat the following periodontally related defects: 1) Intrabony periodontal defects 2) Furcation periodontal defects, and 3) Gingival recession associated with periodontal defects. |
P040024/S005 3/3/06 Special |
Restylane Injectable Gel |
Medicis Aesthetics Holdings, Inc. Scottsdale, AZ 85258 |
Approval for quality control change that provides for additional assurance of the purity of Restylane Injectable Gel device regarding endotoxin level. |
30-Day Notices (135 Day Supplement was not required)
N16837/S004 3/2/06 |
Artegraft Collagen Vascular Graft |
Artegraft, Inc. North Brunswick, NJ 08902 |
Addition of an alternate supplier for the Bovine Carotid Artery component of the device. |
P800022/S054 3/22/06 |
Zyderm Zyplast Collagen Implant, CosmoDerm/ CosmoPlast Human Collagen Implant |
Inamed Corporation Santa Barbara, CA 93111 |
Change of component supplier. |
P810025/S025 3/14/06 |
Amvisc and Amvisc Plus |
Bausch and Lomb San Dimas, CA 91773 |
Removal of the chloroform treatment step from the manufacturing process for the Amvisc and Amvisc Plus. |
P860019/S207 3/2/06 |
Percutaneous Transluminal Coronary Angioplasty Catheters Maverick 2 Monorail, PTCA Catheters and NC Monorail PTCA Catheter |
Boston Scientific Corporation Maple Grove, MN 55311 |
Modification of the equipment nozzle to the mold used for making the manifold of the above-stated devices. |
P910023/S101 3/14/06 |
Epic/Epic+ and Atlas/Atlas+ Family of Pulse Generators |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Change from a manual to an automated system for the soldering of the output flex to feedthru subassemblies on the devices. |
P940031/S051 3/31/06 |
PULSAR/ DISCOVERY/ MERIDIAN |
Guidant Corp. St. Paul, MN 55112 |
Addition of a requirement for the thickness of the gold plating on the accelerometer bond pad for the devices. |
P960004/S034 3/9/06 |
ThinLine/ FINELINE Leads |
Guidant Corporation St. Paul, MN 55112 |
Use of Automatic Vision System for inspecting the presence of coil weld. |
P960013/S016 3/2/06 |
Tendril Model 1488T/TC and 1688T/TC Leads |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Addition of an inspection for medical adhesive on the helix during production. |
P960013/S017 3/2/06 |
Tendril Model 1488T/TC and 1688T/TC Leads |
St. Jude Medical, CRMD Sylmar, CA 91342 |
Addition of an additional crimp depth measurement and record on the manufacturing traveler during production. |
P960040/S109 3/31/06 |
VENTAK Family |
Guidant Corp. St. Paul, MN 55112 |
Moving the process of applying polyimide over the brazed joints from Guidant to the telemetry coil supplier. |
P960040/S111 3/31/06 |
VENTAK AV/VR/PRIZM |
Guidant Corp. St. Paul, MN 55112 |
Addition of a requirement for the thickness of the gold plating on the accelerometer bond pad for the devices. |
P960040/S112 3/31/06 |
VENTAK Family |
Guidant Corp. St. Paul, MN 55112 |
Change to the operator handling/cleaning instructions. |
P960040/S113 3/31/06 |
VENTAK AV/VR/PRIZM |
Guidant Corp. St. Paul, MN 55112 |
Change from laser etching to laser oxidizing for the marking process for pulse generator cans. |
D970003/S061 3/14/06 |
INSIGNIA/NEXUS Family of Implantable Pacemaker Devices |
Guidant Corporation St. Paul, MN 55112 |
Addition of an alternate supplier for the C2 component for the device. |
D970003/S063 3/31/06 |
INSIGNIA, NEXUS |
Guidant Corp. St. Paul, MN 55112 |
Addition of a requirement for the thickness of the gold plating on the accelerometer bond pad for the devices. |
D970003/S065 3/31/06 |
INSIGNIA Family of Pacemakers |
Guidant Corp. St. Paul, MN 55112 |
Addition of an automated inspection process to an existing manual inspection process. |
D970003/S066 3/31/06 |
INSIGNIA and NEXUS Pacemakers |
Guidant Corp. St. Paul, MN 55112 |
Change in vendors for INSIGNIA and NEXUS telemetry coils. |
P980016/S069 3/9/06 |
Marquis, Maximo, InSync, Entrust, and Intrinsic Family of Implantable Cardioverter Defibrillators (ICDs) |
Medtronic, Inc. Shoreview, MN 55126 |
Addition of an in-process Quality Assurance (QA) test to the Final Functional Testing. |
P980053/S010 3/15/06 |
Durasphere Injectable Bulking Agent |
Carbon Medical technologies, Inc. St. Paul, MN 55110 |
Modification to the pouch sealing parameters. |
P990040/S002 3/7/06 |
TRUFILL n-Butyl Cyanoacrylate (nBCA) Liquid Embolic System |
Cordis Neurovascular Miami Lakes, FL 33014 |
Change in the immediate product container to eliminate the white background paint from the aluminum tube containing the product. |
P990040/S003 3/7/06 |
TRUFILL n-Butyl Cyanoacrylate (nBCA) Liquid Embolic System |
Cordis Neurovascular Miami Lakes, FL 33014 |
Change in the dry-heat sterilizer to one of higher capacity. |
P000013/S006 3/14/06 |
Trident Ceramic-on-Ceramic Acetabular System |
Stryker Howmedica Osteonics Corp. Mahwah, NJ 07430 |
Manufacturing process changes by CeramTec, Inc. for the Biolox forte ceramic femoral heads and inserts. |
P010012/S104 3/24/06 |
CONTAK RENEWAL RF Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) |
Guidant Corp. St. Paul, MN 55112 |
Changes to the manufacturing test software. |
P010012/S105 3/14/06 |
RENEWAL Family of CRT-Ds |
Guidant Corp. St. Paul, MN 55112 |
Change from a manual to an automated visual inspection of digital dies. |
P010012/S106 3/31/06 |
CONTAK CD/EASYTRAK Family |
Guidant Corp. St. Paul, MN 55112 |
Change to the placement requirement for the inner seal for the device. |
P010012/S107 3/31/06 |
CONTAK CD Family of CRT-Ds |
Guidant Corp. St. Paul, MN 55112 |
Moving the process of applying polyimide over the brazed joints from Guidant to the telemetry coil supplier. |
P010012/S108 3/24/06 |
EASYTRAK 2 Family of Leads |
Guidant Corp. St. Paul, MN 55112 |
Addition of a second source supplier for the conductor coil used in the device. |
P010012/S111 3/31/06 |
CONTAK CD/ EASYTRAK |
Guidant Corp. St. Paul, MN 55112 |
Addition of a requirement for the thickness of the gold plating on the accelerometer bond pad for the devices. |
P010012/S112 3/31/06 |
CONTAK RENEWAL Family of CRT-Ds |
Guidant Corp. St. Paul, MN 55112 |
Adding an inline underfill process in hybrid manufacturing. |
P010012/S113 3/31/06 |
CONTAK CD/ EASYTRAK |
Guidant Corp. St. Paul, MN 55112 |
Change from a manual to an automated system for inspecting the inner seals present in the device header. |
P010012/S114 3/31/06 |
CONTAK CD/ EASYTRAK |
Guidant Corp. St. Paul, MN 55112 |
Change to the operator handling/cleaning instructions. |
P010012/S115 3/31/06 |
CONTAK CD/ EASYTRAK |
Guidant Corp. St. Paul, MN 55112 |
Change from laser etching to laser oxidizing for the marking process for pulse generator cans. |
P010031/S036 3/9/06 |
Marquis, Maximo, InSync, Entrust, and Intrinsic Family of Implantable Cardioverter Defibrillators (ICDs) |
Medtronic, Inc. Shoreview, MN 55126 |
Addition of an in-process Quality Assurance (QA) test to the Final Functional Testing. |
P020009/S024 3/2/06 |
Express/Express 2 Coronary Stent System |
Boston Scientific Corporation Maple Grove, MN 55311 |
Modification of the equipment nozzle to the mold used for making the manifold of the above-stated devices. |
P020009/S025 3/3/06 |
Express/Express 2 Coronary Stent System |
Boston Scientific Corporation Maple Grove, MN 55311 |
Changes to the mandrel. |
P020022/S004 3/3/06 |
Bayer VERSANT HCV RNA 3.0 Assay (bDNA) |
Bayer Healthcare LLC East Walpole, MA 02032 |
Change in packaging and labeling. |
P030005/S030 3/31/06 |
CONTAK RENEWAL TR |
Guidant Corp. St. Paul, MN 55112 |
Change to the placement requirement for the inner seal for the device. |
P030005/S031 3/31/06 |
CONTAK RENEWAL TR |
Guidant Corp. St. Paul, MN 55112 |
Addition of a requirement for the thickness of the gold plating on the accelerometer bond pad for the devices. |
P030005/S032 3/31/06 |
CONTAK RENEWAL TR |
Guidant Corporation St. Paul, MN 55112 |
Change from laser etching to laser oxidizing for the marking process for pulse generator cans. |
P030025/S026 3/3/06 |
Paclitaxel-eluting Coronary Stent System |
Boston Scientific Corporation Maple Grove, MN 55311 |
Changes to the mandrel. |
P030025/S027 3/29/06 |
Taxus Express2 Coronary Stent System |
Boston Scientific Corporation Maple Grove, MN 55311 |
Change to the processing order for pre-loading the stent protector and the addition of an inspection to verify the stent protector outer diameter. |
P040012/S004 3/24/06 |
RX ACCULINK and ACCULINK Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Reducing sampling AQL for strain relief component dimensional inspection. |
P040012/S005 3/24/06 |
RX ACCULINK and ACCULINK Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Changes implemented to the packaging manufacturing process instruction (MPI2027943, Pouch/Header Bag Packaging Procedure). Changes pertain to the manufacturing inspection of pouch/pouch seal. |
P040012/S006 3/24/06 |
RX ACCULINK and ACCULINK Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Removal of the option of using isopropyl alcohol (IPA) and a dry wipe for removing particulates prior to loading the stent on the delivery system. |
P040012/S007 3/24/06 |
RX ACCULINK and ACCULINK Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Use of new tooling to expand the stents during the stent fabrication operation for the OTW and RX ACCULINK Nitinol stents. |
P040012/S011 3/24/06 |
Acculink and RX Acculink Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Change to the distal outer member bonding procedure. |
P040012/S012 3/24/06 |
Acculink and RX Acculink Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Change to modify the visual inspection criteria for the distal bond junction. |
P040012/S013 3/24/06 |
Acculink and RX Acculink Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Change in the procedure for verifying stent outer diameter during stent cleaning process. |
P040012/S014 3/24/06 |
Acculink and RX Acculink Carotid Stent Systems |
Guidant Corp., Endovascular Solutions Santa Clara, CA 95404 |
Change in the tip bond procedure, deletion of a redundant reinspection and rework process step, and a change in the in-process specification for the tip. |
P040016/S008 3/3/06 |
Liberte Coronary Stent System |
Boston Scientific Corporation Maple Grove, MN 55311 |
Changes to the mandrel. |
P040043/S009 3/9/06 |
GORE TAG Thoracic Endoprosthesis |
W.L. Gore & Associates, Inc. Flagstaff, AZ 86003 |
Updating the visual standard referenced in the post-crush TAG inspection procedure. |
Summary of PMA Originals & Supplements Approved
Originals:
3
Supplements: 89
Summary of PMA Originals Under Review
Total
Under Review: 101
Total Active: 43
Total On Hold: 58
Number Greater Than 180 Days: 4
Summary of PMA Supplements Under Review
Total
Under Review: 403
Total Active: 229
Total On Hold: 174
Number Greater Than 180 Days: 11
Summary of All PMA Submissions Received
Originals: 7
Supplements: 104
Summary of PMA Supplement PMA Approval/Denial Decision Times
Number of Approvals: 89
Number of Denials: 0
Average Days Fr Receipt to Decision (Total Time): 88.4
FDA Time: 68.2 Days MFR Time: 20.2 Days
Updated July 5, 2006
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH